Digirad raises $21 million in financing:
This article was originally published in Clinica
Digirad, which manufactures and markets solid-state gamma cameras for use in nuclear medicine, has completed a $21 million round of private equity financing. The San Diego, California company will use the funds to continue growing its product and service businesses. Digirad has received over 80 orders for its camera, with 40 units delivered. The company expects to make and deliver over 100 cameras during 2001. Its nuclear cardiology service business, Orion Imaging Systems, has been expanded and serves over 60 physician/customer sites.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.